Vadadustat

N/A

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug NameVadadustat
Drug Alias Name伐度司他Vadadustatum伐达度司他VAFSEOバフセオ +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsAnemiaKidney Failure, Chronic +[9] 
Global Approved IndicationsAnemiaRenal Insufficiency, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2020/06/29
Country/TerritoryCzechiaBulgariaCanada +[33] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAkebia Therapeutics IncOtsuka Holdings Co LtdProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesCardinal Health IncThe University Of Texas Health Science Center At HoustonMedice Arzneimittel Pütter Gmbh & Co Kg +[7] 
Inactive CompaniesMitsubishi Tanabe Pharma CorpOtsuka Pharmaceutical Co Ltd
Active IndicationsAnemiaRenal Insufficiency, ChronicRespiratory Distress Syndrome, Adult +[5] 
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsKidney Failure, ChronicKidney Diseases +[4] 

Other Information

ATC CodeB03XA08
Related LinksWikipediaDrugBankKEGG